Infarct size of fibrocytes to increase risk of heart attack
According to a study in American Heart Journal Circulating fibrocytes measured 6 months after STEMI positively correlate with 6-month infarct size assessed by cardiac magnetic resonance imaging. Fibrocytes have been shown to home to the injured myocardium in patients with myocardial infarction, and the concentration of circulating fibrocytes is a serious risk factor that has to be considered.
Heart attack is classically is characterized by ST-segment elevation myocardial infarction (STEMI). It is one type of myocardial infarction in which a part of the heart muscle (myocardium) has died due to the obstruction of blood supply to the area. Infarct size is a strong predictor of outcomes after ST elevation myocardial infarction. Circulating fibrocytes are bone marrow-derived progenitor cells associated with fibrotic processes.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.